Activity update on therapeutics

Article

The increased activity in ophthalmic research is reflected in the long list of clinical studies in their various stages: nearly 300 studies of various aspects of glaucoma and close to 250 studies on ocular surface, cornea and dry eye.

"The increased activity in ophthalmic research is reflected in the long list of clinical studies in their various stages: nearly 300 studies of various aspects of glaucoma and close to 250 studies on ocular surface, cornea and dry eye. Searching the web for retina clinical studies yields about 250 studies, about 190 studies are listed for macular edema and approximately 70 studies for AMD. This clinical bustle heralds the changes that we will soon see in the practice of ophthalmology," so says Sara Krupsky, one of the organiers of the 8th Symposium on Ocular Pharmacology and Therapeutics (ISOPT) in Rome 3–6 December.

"The landscape of ocular therapeutics cannot be fully portrayed without bringing up innovations in ocular drug delivery such as slow release devices implanted in the eye. ISOPT 2009 will accordingly bring to focus the latest novelties in medical devices," continued Dr Krupsky.

The ISOPT programme is geared to provide a continuum, spreading from basic development of therapeutic concepts to their utilization as drugs and technologies in clinical reality. Considerations common to drug development will be discussed with researchers based in academia, clinical investigators, regulatory affairs and industry professionals.

www.isopt2009.com

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.